Affymax Alternatives & Competitors
12 companies similar to Affymax — Pioneering innovative therapies for life-threatening conditions, aiming to enhan...
Companies similar to Affymax
Cara Therapeutics
Transforming the way pruritus is treated to bring quality to the lives of those who suffer
Agennix
Crafting novel therapies to enhance the length and quality of life for seriously ill patie...
American Renal Associates
Working together to provide the highest quality care.
Scout Bio
Shaping the future of veterinary medicine through one-time therapies for major chronic pet...
Rival Readout
Competing with Affymax? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ocera Therapeutics
Dedicated to Innovation in Liver Disease Treatment, Pioneering Life-Saving Therapeutics fo...
HighTide Therapeutics
East Meets West—The Quest for Cure
Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoi...
Cirius Therapeutics
Pioneering the future of liver and metabolic disease treatment with innovative insulin sen...
Athersys
Committed to developing therapies to extend and enhance the quality of life.
Zavante Therapeutics
A clinical-stage biopharmaceutical pioneer advancing novel therapies to enhance the outcom...
Atorvia Health Technologies
Fearlessly tackling kidney failure
About Affymax
Affymax is a biopharmaceutical company founded in 2001 with a focus on pioneering innovative therapies for life-threatening conditions. Their flagship product candidate, peginesatide (previously known as Hematide™), has completed Phase 3 trials for treating anemia in chronic kidney disease (CKD) patients. The company h...
Biopharmaceutical Company, Drug Development, Innovative Therapies, Anemia Treatment, Chronic Kidney Disease, Peginesatide, Phase 3 Trials, FDA Review, New Drug Application, Life-threatening Conditions, Dialysis Patients
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Affymax: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Affymax on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.